Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) Demonstrating No Change in In Vitro Potency Against Indicated Pathogens
July 31, 2024 07:30 ET
|
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline)
Antimicrobial Resistance Surveillance Market Size to Hit US$ 9.50 Billion by 2032, Rising Prevalence of Drug-Resistant Infections Drives Growth | Research by SNS Insider
July 22, 2024 13:47 ET
|
SNS Insider pvt ltd
Pune, July 22, 2024 (GLOBE NEWSWIRE) -- Antimicrobial Resistance Surveillance Market Size Analysis: “According to SNS Insider Research, The Antimicrobial Resistance Surveillance Market is...
$230+ Bn Anti-Infectives Markets - Global Strategic Business Report to 2030: Telemedicine and Digital Health Platforms Drives Adoption, Rising Prevalence of Drug-Resistant Infections Spurs Innovation
July 22, 2024 09:15 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Anti-Infectives - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Anti-Infectives...
AUROBAC THERAPEUTICS APPOINTS SCIENTIFIC ADVISORY BOARD
June 20, 2024 08:00 ET
|
AUROBAC THERAPEUTICS
The newly formed Scientific Advisory Board chaired by Dr. Marco Taglietti will provide technical and strategic guidance to support AUROBAC’s R&D strategy. Lyon (France), June 20, 2024 ...
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
June 03, 2024 08:14 ET
|
AUROBAC THERAPEUTICS
AUROBAC THERAPEUTICS to advance ATX101 in septic shock, and multiple preclinical and discovery programs targeting Gram-negative pathogens. Lyon (France), June 3, 2024 AUROBAC THERAPEUTICS, a...
Antibiotic Resistance Markets Therapeutics, by Pathogen and Therapy Type to 2027: Search for Alternatives to Antibiotics Creates New Global Goldrush
May 27, 2024 03:01 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization....
Global Cephalosporin Drug Market Report 2024 Insights and Forecasts 2019-2022 and 2023-2029 - The Role of Advanced Cephalosporin Formulations, New Generations and Combination Therapies in Development
February 22, 2024 06:16 ET
|
Research and Markets
Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Cephalosporin Drug Market (2024 Edition): Analysis by Generation, Route of Administration, Application (Respiratory Tract Infection, Skin...
Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen & Technology 2023-2027, with Profiles of 30 Companies Including Accelerate Diagnostics, Binx Health, GeneFluidics & OpGen
February 16, 2024 04:08 ET
|
Research and Markets
Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization 2023 to 2027"...
Antimicrobial Resistance Surveillance Market: Projected Growth at 5.6% CAGR Through 2028
January 23, 2024 06:13 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public...
LifeArc - New UK-India research project trialling easy-to-use test to help fight against global threat of antimicrobial resistance
November 30, 2023 02:00 ET
|
LifeArc
New UK-India research project trialling easy-to-use test to help fight against global threat of antimicrobial resistance The second round of the Diagnostics for One Health and User Driven Solutions...